Wells Fargo & Company MN boosted its stake in Dynavax Technologies Corp. by 4.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 14,433 shares of the biopharmaceutical company’s stock after buying an additional 563 shares during the period.
Category: Dynavax Technologies
Deadline Upcoming in $4.5 Million Settlement in the Dynavax…
The Shareholders Foundation announced that a deadline is coming up on January 21, 2017 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Dynavax Technologies Corporation between April 26, 2012 and June 10, 2013. Investors who purchased a significant amount of shares of Dynavax Technologies Corporation between April 26, 2012 and June 10, 2013, have certain options and should contact the Shareholders Foundation by email at mail@shareholdersfoundation.com or call 858-779-1554.